Identifying medications underlying communication atypicalities in psychotic and affective disorders: A pharmacosurveillance study within the FDA Adverse Event Reporting System

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Michele Fusaroli, Arndis Simonsen, Stephanie A. Borrie, Daniel M. Low, Alberto Parola, Emanuel Raschi, Elisabetta Poluzzi, Riccardo Fusaroli

Journal title: medXriv

Journal publisher: medXriv

Published year: 2022

DOI identifier: 10.1101/2022.09.05.22279609